The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death

被引:459
作者
Basu, A [1 ]
Haldar, S [1 ]
机构
[1] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Pharmacol, Ireland Canc Ctr,Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA
关键词
apoptosis; Bax; Bcl2; cell cycle; p53;
D O I
10.1093/molehr/4.12.1099
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Each cell is under constant surveillance to maintain the integrity of its genome. Genomic lesions in a cell must be repaired before the onset of DNA replication and cell division. In the scenario that the genomic lesion is not repairable, the damaged cells are disposed in an orderly manner known as programmed cell death or apoptosis. Apoptosis and cell cycle progression are two intimately linked phenomena. Uncontrollable cell proliferation perturbs the cellular homeostasis and this can lead to malignancies, as well as organ dysfunction and developmental abnormalities. The biological pathway controlling cell fate is sequentially organized at the molecular level. Recent studies have made important contributions in advancing our knowledge of the mechanisms of cell cycle control and apoptosis regulation. A oncogene-derived protein, Bcl2, confers negative control in the pathway of cellular suicide machinery. A Bcl2-homologous protein, Bax, promotes cell death by competing with Bcl2. While Bax-Bax homodimers act as apoptosis inducers, Bcl2-Bax heterodimer formation evokes a survival signal for the cells. Both Bcl2 and Bax are transcriptional targets for the tumour suppressor protein, p53, which induces cell cycle arrest or apoptosis in response to DNA damage. In all, the coordinate performance of these molecules is crucial for controlling life and death of a cell.
引用
收藏
页码:1099 / 1109
页数:11
相关论文
共 127 条
[11]  
Boulakia CA, 1996, ONCOGENE, V12, P529
[12]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[13]   GROWTH-FACTOR MODULATION OF P53-MEDIATED GROWTH ARREST VERSUS APOPTOSIS [J].
CANMAN, CE ;
GILMER, TM ;
COUTTS, SB ;
KASTAN, MB .
GENES & DEVELOPMENT, 1995, 9 (05) :600-611
[14]   Identification of a novel regulatory domain in Bcl-x(L) and Bcl-2 [J].
Chang, BS ;
Minn, AJ ;
Muchmore, SW ;
Fesik, SW ;
Thompson, CB .
EMBO JOURNAL, 1997, 16 (05) :968-977
[15]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[16]  
Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573
[17]   INDUCTION OF APOPTOSIS BY THE BCL-2 HOMOLOG BAK [J].
CHITTENDEN, T ;
HARRINGTON, EA ;
OCONNOR, R ;
FLEMINGTON, C ;
LUTZ, RJ ;
EVAN, GI ;
GUILD, BC .
NATURE, 1995, 374 (6524) :733-736
[18]   A CONSERVED DOMAIN IN BAK, DISTINCT FROM BH1 AND BH2, MEDIATES CELL-DEATH AND PROTEIN-BINDING FUNCTIONS [J].
CHITTENDEN, T ;
FLEMINGTON, C ;
HOUGHTON, AB ;
EBB, RG ;
GALLO, GJ ;
ELANGOVAN, B ;
CHINNADURAI, G ;
LUTZ, RJ .
EMBO JOURNAL, 1995, 14 (22) :5589-5596
[19]  
Chresta CM, 1996, CANCER RES, V56, P1834
[20]  
CLARKE AR, 1994, ONCOGENE, V9, P1767